Download PDF
Semin Thromb Hemost 2021; 47(05): 512-519
DOI: 10.1055/s-0041-1722971
Review Article

Altered Fibrinolysis during and after Surgery

Maria J. Colomina 
1   Department of Anaesthesia and Critical Care, Bellvitge University Hospital, L'Hospitalet de LLobregat, Barcelona, Spain
2   Universidad de Barcelona, Barcelona, Spain
,
Esther Méndez
1   Department of Anaesthesia and Critical Care, Bellvitge University Hospital, L'Hospitalet de LLobregat, Barcelona, Spain
,
Antoni Sabate
1   Department of Anaesthesia and Critical Care, Bellvitge University Hospital, L'Hospitalet de LLobregat, Barcelona, Spain
2   Universidad de Barcelona, Barcelona, Spain
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Major surgery induces hemostatic changes related to surgical stress, tissue destruction, and inflammatory reactions. These changes involve a shift of volume from extravascular space to intravascular and interstitial spaces, a “physiologic” hemodilution of coagulation proteins, and an increase of plasmatic fibrinogen concentration and platelets. Increases in fibrinogen and platelets together with a simultaneous dilution of pro- and anticoagulant factors and development of a hypofibrinolytic status result in a postoperative hypercoagulable state. This profile is accentuated in more extensive surgery, but the balance can shift toward hemorrhagic tendency in specific types of surgeries, for example, in prolonged cardiopulmonary bypass or in patients with comorbidities, especially liver diseases, sepsis, and hematological disorders. Also, acquired coagulopathy can develop in patients with trauma, during obstetric complications, and during major surgery as a result of excessive blood loss and subsequent consumption of coagulation factors as well as hemodilution. In addition, an increasing number of patients receive anticoagulants and antiplatelet drugs preoperatively that might influence the response to surgical hemostasis. This review focuses on those situations that may change normal hemostasis and coagulation during surgery, producing both hyperfibrinolysis and hypofibrinolysis, such as overcorrection with coagulation factors, bleeding and hyperfibrinolysis that may occur with extracorporeal circulation and high aortic-portal-vena cava clamps, and hyperfibrinolysis related to severe maintained hemodynamic disturbances. We also evaluate the role of tranexamic acid for prophylaxis and treatment in different surgical settings, and finally the value of point-of-care testing in the operating room is commented with regard to investigation of fibrinolysis.

Keywords

surgery - hyperfibrinolysis - hypofibrinolysis - hemostasis - tranexamic acid

Authors' Contributions

M.J.C. and A.S. contributed to the conception, design and writing of the manuscript. A.S. and E.M. contributed in the literature search, data collection, and editing of the manuscript. M.J.C. and A.S. contributed to the editing and revision of the manuscript.


Ethical Approval

This study does not contain any human participants. The clinical case patient released their clinical data for publication by means of specific informed consent.




Publication History

Article published online:
20 April 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Kolev K, Longstaff C. Bleeding related to disturbed fibrinolysis. Br J Haematol 2016; 175 (01) 12-23
    CrossrefPubMedGoogle Scholar
  • 2 Griffiths NJ. Factors affecting the fibrinolytic response to surgery. Ann R Coll Surg Engl 1979; 61 (01) 12-16
    PubMedGoogle Scholar
  • 3 Nicolau-Raducu R, Beduschi T, Vianna R. et al. Fibrinolysis shutdown is associated with thrombotic and hemorrhagic complications and poorer outcomes after liver transplantation. Liver Transpl 2019; 25 (03) 380-387
    CrossrefPubMedGoogle Scholar
  • 4 Hartmann M, Szalai C, Saner FH. Hemostasis in liver transplantation: pathophysiology, monitoring, and treatment. World J Gastroenterol 2016; 22 (04) 1541-1550
    CrossrefPubMedGoogle Scholar
  • 5 Bevilacqua MP, Schleef RR, Gimbrone Jr MA, Loskutoff DJ. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 1986; 78 (02) 587-591
    CrossrefPubMedGoogle Scholar
  • 6 Kassis J, Hirsh J, Podor TJ. Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood 1992; 80 (07) 1758-1764
    CrossrefPubMedGoogle Scholar
  • 7 Chandler WL, Fitch JC, Wall MH. et al. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass. Thromb Haemost 1995; 74 (05) 1293-1297
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Gando S, Tedo I. Fibrinolytic shutdown after cardiopulmonary bypass surgery is caused by circulating cytokines during operation, accompanied by endothelial injury. J Anesth 1995; 9 (01) 17-21
    CrossrefPubMedGoogle Scholar
  • 9 Schols SEM, Lancé MD, Feijge MA H. et al. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Thromb Haemost 2010; 103 (02) 318-328
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113 (05) 1205-1219
    CrossrefPubMedGoogle Scholar
  • 11 Chee YE, Liu SE, Irwin MG. Management of bleeding in vascular surgery. Br J Anaesth 2016; 117 (Suppl. 02) ii85-ii94
    CrossrefPubMedGoogle Scholar
  • 12 Aquina CT, Blumberg N, Becerra AZ. et al. Association among blood transfusion, sepsis, and decreased long-term survival after colon cancer resection. Ann Surg 2017; 266 (02) 311-317
    CrossrefPubMedGoogle Scholar
  • 13 Jakobsen CJ, Ryhammer PK, Tang M, Andreasen JJ, Mortensen PE. Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients. Eur J Cardiothorac Surg 2012; 42 (01) 114-120
    CrossrefPubMedGoogle Scholar
  • 14 Liu L, Wang Z, Jiang S. et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS One 2013; 8 (05) e64261
    CrossrefPubMedGoogle Scholar
  • 15 Levy JH, Dutton RP, Hemphill III JC. et al; Hemostasis Summit Participants. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 2010; 110 (02) 354-364
    CrossrefPubMedGoogle Scholar
  • 16 Ogawa S, Ohnishi T, Hosokawa K, Szlam F, Chen EP, Tanaka KA. Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions. Br J Anaesth 2013; 111 (06) 1013-1023
    CrossrefPubMedGoogle Scholar
  • 17 Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010; 104 (03) 318-325
    CrossrefPubMedGoogle Scholar
  • 18 Kozek-Langenecker SA. Fluids and coagulation. Curr Opin Crit Care 2015; 21 (04) 285-291
    CrossrefPubMedGoogle Scholar
  • 19 Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003; 96 (05) 1453-1459
    CrossrefPubMedGoogle Scholar
  • 20 Schaden E, Wetzel L, Kozek-Langenecker S, Thaler U, Scharbert G. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation. Br J Anaesth 2012; 109 (04) 572-577
    CrossrefPubMedGoogle Scholar
  • 21 Rasmussen KC, Johansson PI, Højskov M. et al. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Ann Surg 2014; 259 (02) 249-254
    CrossrefPubMedGoogle Scholar
  • 22 Larsen OH, Fenger-Eriksen C, Ingerslev J, Sørensen B. Improved point-of-care identification of hyperfibrinolysis is needed. Thromb Res 2012; 130 (04) 690-691
    CrossrefPubMedGoogle Scholar
  • 23 Fenger-Eriksen C, Christiansen K, Laurie J, Sørensen B, Rea C. Fibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution. Thromb Res 2013; 131 (05) e210-e213
    CrossrefPubMedGoogle Scholar
  • 24 Jalaer I, Tsakiris DA, Solecka-Witulska BA, Kannicht C. The role of von Willebrand factor in primary haemostasis under conditions of haemodilution. Thromb Res 2017; 157: 142-146
    CrossrefPubMedGoogle Scholar
  • 25 Sniecinski RM, Karkouti K, Levy JH. Managing clotting: a North American perspective. Curr Opin Anaesthesiol 2012; 25 (01) 74-79
    CrossrefPubMedGoogle Scholar
  • 26 Zhao J, Yang D, Zheng D. Coagulation is more affected by quick than slow bleeding in patients with massive blood loss. Blood Coagul Fibrinolysis 2017; 28 (02) 121-125
    CrossrefPubMedGoogle Scholar
  • 27 Moore HB, Moore EE. Temporal changes in fibrinolysis following injury. Semin Thromb Hemost 2020; 46 (02) 189-198
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 De Robertis E, Kozek-Langenecker SA, Tufano R, Romano GM, Piazza O, Zito Marinosci G. Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding. Minerva Anestesiol 2015; 81 (01) 65-75
    PubMedGoogle Scholar
  • 29 Saes JL, Schols SEM, van Heerde WL, Nijziel MR. Hemorrhagic disorders of fibrinolysis: a clinical review. J Thromb Haemost 2018; DOI: 10.1111/jth.14160.
    CrossrefPubMedGoogle Scholar
  • 30 Mitrophanov AY, Szlam F, Sniecinski RM, Levy JH, Reifman J. Controlled multifactorial coagulopathy: effects of dilution, hypothermia, and acidosis on thrombin generation in vitro. Anesth Analg 2020; 130 (04) 1063-1076
    CrossrefPubMedGoogle Scholar
  • 31 Mosnier LO, Meijers JC, Bouma BN. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb Haemost 2001; 85 (01) 5-11
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ. Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis. Curr Drug Targets 2019; 20 (16) 1695-1701
    CrossrefPubMedGoogle Scholar
  • 33 Rayt HS, Merker L, Davies RS. Coagulation, fibrinolysis, and platelet activation following open surgical or percutaneous angioplasty revascularization for symptomatic lower limb chronic ischemia. Vasc Endovascular Surg 2016; 50 (03) 193-201
    CrossrefPubMedGoogle Scholar
  • 34 Pärsson H, Holmberg A, Siegbahn A, Bergqvist D. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation. Eur J Vasc Endovasc Surg 2004; 27 (02) 186-192
    CrossrefPubMedGoogle Scholar
  • 35 Abdelhamid MF, Davies RS, Vohra RK, Adam DJ, Bradbury AW. Effect of endovascular and open abdominal aortic aneurysm repair on thrombin generation and fibrinolysis. J Vasc Surg 2013; 57 (01) 103-107
    CrossrefPubMedGoogle Scholar
  • 36 Polok KJ, Górka J, Fronczek J. et al. Impact of arterial procedures on coagulation and fibrinolysis - a pilot study. Rev Bras Cir Cardiovasc 2019; 34 (03) 327-334
    CrossrefPubMedGoogle Scholar
  • 37 Górka J, Polok K, Fronczek J. et al. Myocardial injury is more common than deep venous thrombosis after vascular surgery and is associated with a high one year mortality risk. Eur J Vasc Endovasc Surg 2018; 56 (02) 264-270
    CrossrefPubMedGoogle Scholar
  • 38 Górka J, Polok K, Iwaniec T. et al. Altered preoperative coagulation and fibrinolysis are associated with myocardial injury after non-cardiac surgery. Br J Anaesth 2017; 118 (05) 713-719
    CrossrefPubMedGoogle Scholar
  • 39 López Y, Páramo JA, Valentí JR, Pardo F, Montes R, Rocha E. Hemostatic markers in surgery: a different fibrinolytic activity may be of pathophysiological significance in orthopedic versus abdominal surgery. Int J Clin Lab Res 1997; 27 (04) 233-237
    CrossrefPubMedGoogle Scholar
  • 40 Guler N, Burleson A, Syed D. et al. Fibrinolytic dysregulation in total joint arthroplasty patients: potential clinical implications. Clin Appl Thromb Hemost 2016; 22 (04) 372-376
    CrossrefPubMedGoogle Scholar
  • 41 Yoshida K, Wada H, Hasegawa M. et al. Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux. Int J Hematol 2012; 95 (02) 160-166
    CrossrefPubMedGoogle Scholar
  • 42 Colucci M, Binetti BM, Branca MG. et al. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology 2003; 38 (01) 230-237
    CrossrefPubMedGoogle Scholar
  • 43 Roullet S, Freyburger G, Labrouche S. et al. Hyperfibrinolysis during liver transplantation is associated with bleeding. Thromb Haemost 2015; 113 (05) 1145-1148
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Samson AL, Alwis I, Maclean JAA. et al. Endogenous fibrinolysis facilitates clot retraction in vivo. Blood 2017; 130 (23) 2453-2462
    CrossrefPubMedGoogle Scholar
  • 45 Wada T, Gando S, Ono Y. et al. Disseminated intravascular coagulation with the fibrinolytic phenotype predicts the outcome of patients with out-of-hospital cardiac arrest. Thromb J 2016; 14: 43
    CrossrefPubMedGoogle Scholar
  • 46 Skorko A, Mumford A, Thomas M. et al. Platelet dysfunction after out of hospital cardiac arrest. Results from POHCAR: a prospective observational, cohort study. Resuscitation 2019; 136: 105-111
    CrossrefPubMedGoogle Scholar
  • 47 Schwameis M, Schober A, Schörgenhofer C. et al. Asphyxia by drowning induces massive bleeding due to hyperfibrinolytic disseminated intravascular coagulation. Crit Care Med 2015; 43 (11) 2394-2402
    CrossrefPubMedGoogle Scholar
  • 48 Skagius E, Siegbahn A, Bergqvist D, Henriksson AE. Fibrinolysis in patients with an abdominal aortic aneurysm with special emphasis on rupture and shock. J Thromb Haemost 2008; 6 (01) 147-150
    CrossrefPubMedGoogle Scholar
  • 49 Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054
    CrossrefPubMedGoogle Scholar
  • 50 Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg 2013; 100 (10) 1271-1279
    CrossrefPubMedGoogle Scholar
  • 51 Robertshaw HJ. An anti-inflammatory role for tranexamic acid in cardiac surgery?. Crit Care 2008; 12 (01) 105
    CrossrefPubMedGoogle Scholar
  • 52 Kozek-Langenecker SA, Ahmed AB, Afshari A. et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. Eur J Anaesthesiol 2017; 34 (06) 332-395
    CrossrefPubMedGoogle Scholar
  • 53 Waldén K, Shams Hakimi C, Jeppsson A, Karlsson M. Effects of fibrinogen supplementation on clot formation in blood samples from cardiac surgery patients before and after tranexamic acid administration. Transfus Med 2019; 29 (05) 319-324
    CrossrefPubMedGoogle Scholar
  • 54 Monaco F, Nardelli P, Pasin L. et al. Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial. Br J Anaesth 2020; 124 (01) 35-43
    CrossrefPubMedGoogle Scholar
  • 55 Dalmau A, Sabaté A, Acosta F. et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg 2000; 91 (01) 29-34
    CrossrefPubMedGoogle Scholar
  • 56 Dalmau A, Sabaté A, Koo M. et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Liver Transpl 2004; 10 (02) 279-284
    CrossrefPubMedGoogle Scholar
  • 57 Dalmau A, Sabaté A, Koo M, Rafecas A, Figueras J, Jaurrieta E. Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation. Anesth Analg 2001; 93 (02) 516
    CrossrefPubMedGoogle Scholar
  • 58 Fillingham YA, Ramkumar DB, Jevsevar DS. et al. The safety of tranexamic acid in total joint arthroplasty: a direct meta-analysis. J Arthroplasty 2018; 33 (10) 3070.e1-3082.e1
    PubMedGoogle Scholar
  • 59 Xu S, Chen JY, Zheng Q. et al. The safest and most efficacious route of tranexamic acid administration in total joint arthroplasty: a systematic review and network meta-analysis. Thromb Res 2019; 176: 61-66
    CrossrefPubMedGoogle Scholar
  • 60 Myles PS, Smith JA, Forbes A. et al; ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 2017; 376 (02) 136-148
    CrossrefPubMedGoogle Scholar
  • 61 HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 2020; 395 (10241): 1927-1936
    CrossrefPubMedGoogle Scholar
  • 62 Kim EH, Song SH, Kim GS, Ko JS, Gwak MS, Lee SK. Evaluation of “flat-line” thromboelastography after reperfusion during liver transplantation. Transplant Proc 2015; 47 (02) 457-459
    CrossrefPubMedGoogle Scholar
  • 63 Abuelkasem E, Lu S, Tanaka K, Planinsic R, Sakai T. Comparison between thrombelastography and thromboelastometry in hyperfibrinolysis detection during adult liver transplantation. Br J Anaesth 2016; 116 (04) 507-512
    CrossrefPubMedGoogle Scholar
  • 64 Roullet S, Labrouche S, Mouton C. et al. Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation. J Clin Pathol 2019; 72 (01) 58-65
    CrossrefPubMedGoogle Scholar
  • 65 Roullet S, Labrouche S, Freyburger G. Fibrinolysis during liver transplantation: analysis by the thrombodynamics method. J Clin Pathol 2019; 72 (09) 636-638
    CrossrefPubMedGoogle Scholar